Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone in Anorexia Nervosa
NCT01121211Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Apr 2010
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Testosterone TEPI patch in anorexia nervosa (AN) (2 arms), sponsored by Massachusetts General Hospital. Primary endpoints: Change From Baseline in Weight at 24 weeks and Change From Baseline in Depression Symptom Severity at 24 weeks. Started Apr 2010; status: completed.
02
Drugs
Testosterone TEPI patch
03
Conditions
anorexia nervosa (AN)
Beyond the preview
Go deeper on NCT01121211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01121211.